-
1
-
-
0028837352
-
Physiology of penile erection
-
Anderson K.-E., Wagner G. Physiology of penile erection. Physiol Rev. 75:1995;191-236.
-
(1995)
Physiol Rev
, vol.75
, pp. 191-236
-
-
Anderson, K.-E.1
Wagner, G.2
-
2
-
-
0030984380
-
The influence of medication on erectile dysfunction
-
Meinhardt W., Kropmann R.F., Vermeig P., et al. The influence of medication on erectile dysfunction. Int J Impot Res. 9:1997;17-26.
-
(1997)
Int J Impot Res
, vol.9
, pp. 17-26
-
-
Meinhardt, W.1
Kropmann, R.F.2
Vermeig, P.3
-
3
-
-
0025081992
-
Nitric oxide and cyclic GMP formation upon electric field stimulation cause relaxation of corpus cavernosum smooth muscle
-
Ignarro L.J., Bush P.A., Buga G.M., et al. Nitric oxide and cyclic GMP formation upon electric field stimulation cause relaxation of corpus cavernosum smooth muscle. Biochem Biophys Res Commun. 170:1990;843-850.
-
(1990)
Biochem Biophys Res Commun
, vol.170
, pp. 843-850
-
-
Ignarro, L.J.1
Bush, P.A.2
Buga, G.M.3
-
5
-
-
0034660235
-
Erectile dysfunction
-
Lue T.F. Erectile dysfunction. N Engl J Med. 342:2000;1802-1813.
-
(2000)
N Engl J Med
, vol.342
, pp. 1802-1813
-
-
Lue, T.F.1
-
6
-
-
0027752805
-
Mechanism of disease: The L-argininenitric-oxide pathway
-
Moncada S. Mechanism of disease the L-argininenitric-oxide pathway . N Engl J Med. 329:1993;2002-2012.
-
(1993)
N Engl J Med
, vol.329
, pp. 2002-2012
-
-
Moncada, S.1
-
7
-
-
0030154874
-
Sildenafil - An orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction
-
Boolell M., Allen M.J., Ballard S.A., et al. Sildenafil - an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res. 8:1996;47-52.
-
(1996)
Int J Impot Res
, vol.8
, pp. 47-52
-
-
Boolell, M.1
Allen, M.J.2
Ballard, S.A.3
-
8
-
-
0036192244
-
Activators of soluble guanylyl cyclase for the treatment of male erectile dysfunction
-
Brioni J.D., Nakane M., Hsieh G.C., et al. Activators of soluble guanylyl cyclase for the treatment of male erectile dysfunction. Int J Impot Res. 14:2002;8-14.
-
(2002)
Int J Impot Res
, vol.14
, pp. 8-14
-
-
Brioni, J.D.1
Nakane, M.2
Hsieh, G.C.3
-
9
-
-
0036227586
-
Nitric oxide independent activation of guanylate cyclase by YC-1 causes erectile responses in the rat
-
Mizusawa H, Hedlund P, Brioni JD, et al: Nitric oxide independent activation of guanylate cyclase by YC-1 causes erectile responses in the rat. J Urol 167: 2276-2281, 2002.
-
(2002)
J Urol
, vol.167
, pp. 2276-2281
-
-
Mizusawa, H.1
Hedlund, P.2
Brioni, J.D.3
-
10
-
-
0035826261
-
NO-independent regulatory site on soluble guanylate cyclase
-
Stasch J.-P., Becker E.M., Alonso Alija C., et al. NO-independent regulatory site on soluble guanylate cyclase. Nature. 401:2001;212-215.
-
(2001)
Nature
, vol.401
, pp. 212-215
-
-
Stasch, J.-P.1
Becker, E.M.2
Alonso Alija, C.3
-
12
-
-
0034875325
-
A conscious-rabbit model to study vardenafil hydrochloride and other agents that influence penile erection
-
Bischoff E., Schneider K. A conscious-rabbit model to study vardenafil hydrochloride and other agents that influence penile erection. Int J Impot Res. 13:2001;230-235.
-
(2001)
Int J Impot Res
, vol.13
, pp. 230-235
-
-
Bischoff, E.1
Schneider, K.2
-
13
-
-
0035092722
-
The oral efficacy of vardenafil hydrochloride for inducing penile erection in a conscious rabbit model
-
Bischoff E., Niewoehner U., Haning H., et al. The oral efficacy of vardenafil hydrochloride for inducing penile erection in a conscious rabbit model. J Urol. 165:2001;1316-1318.
-
(2001)
J Urol
, vol.165
, pp. 1316-1318
-
-
Bischoff, E.1
Niewoehner, U.2
Haning, H.3
|